Boehringer Ingelheim today announces the start of the THULITE Phase II clinical study (NCT06962839). It will investigate the efficacy, safety and tolerability of BI ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

ABSTRACT: Introduction: DM has been implicated with multiple complications including diabetic cardiac autonomic neuropathy (DCAN), with a global burden ranging from 1% - 90% in type 1 DM and 20% - 73% ...

Diabetic neuropathy also may simulate tumors or degenerative diseases of the nervous system or malignancy of the gastrointestinal tract.

The Diabetic Peripheral Neuropathy drugs in development market research report provides comprehensive information on the therapeutics under development for Diabetic Peripheral Neuropathy, complete ...

Research reveals xanthones as promising agents in diabetes management, offering antioxidant, anti-inflammatory, and insulin-sensitizing benefits.

The idea that sensory neuropathy affects small fibers and that painful neuropathy affects large fibers must be reconsidered, said a diabetologist.

Diabetic peripheral neuropathy (DPN) is a chronic and prevalent metabolic disease that gravely endangers human health and seriously affects the quality of life of hyperglycemic patients. More ...

Now, working with mice, Salk Institute researchers have identified another factor contributing to diabetes-associated peripheral neuropathy: altered amino acid metabolism. The team found that diabetic ...